CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-14 | MOATAZEDI DAVID See Remarks | Sale | −64,211 | $8.47 | $544K | 615,677 |
| 2023-03-14 | Avelar Rui See Remarks | Sale | −14,906 | $8.47 | $126K | 335,925 |
| 2023-02-17 | Alphaeon 1 LLC 10% owner | Sale | −1,850,000 | $8.40 | $15.5M | 4,214,871 |
| 2023-02-07 | Medytox Inc. 10% owner | Sale | −2,187,511 | $8.50 | $18.6M | 5,071,989 |
| 2023-01-27 | Stewart Brady Director | Grant or award | +8,293 | 44,801 | ||
| 2023-01-27 | Stewart Brady Director | Grant or award · Stock Option (Right to Buy) | +11,789 | 11,789 | ||
| 2023-01-27 | HAYMAN ROBERT Director | Grant or award | +8,293 | 48,174 | ||
| 2023-01-27 | HAYMAN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +11,789 | 11,789 | ||
| 2023-01-27 | Malik Vikram Director | Grant or award | +8,293 | 77,585 | ||
| 2023-01-27 | Malik Vikram Director | Grant or award · Stock Option (Right to Buy) | +11,789 | 11,789 | ||
| 2023-01-27 | Parschauer Karah Herdman Director | Grant or award | +8,293 | 43,174 | ||
| 2023-01-27 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to Buy) | +11,789 | 11,789 | ||
| 2023-01-27 | BLANK SIMONE Director | Grant or award | +8,293 | 63,174 | ||
| 2023-01-27 | BLANK SIMONE Director | Grant or award · Stock Option (Right to Buy) | +11,789 | 11,789 | ||
| 2023-01-27 | GILL DAVID N Director | Grant or award | +8,293 | 37,861 | ||
| 2023-01-27 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +11,789 | 11,789 | ||
| 2023-01-27 | FARRELL PETER C Director | Grant or award | +8,293 | 43,174 | ||
| 2023-01-27 | FARRELL PETER C Director | Grant or award · Stock Option (Right to Buy) | +11,789 | 11,789 | ||
| 2023-01-25 | Avelar Rui See Remarks | Grant or award | +97,642 | 350,831 | ||
| 2023-01-25 | Avelar Rui See Remarks | Grant or award · Stock Option (Right to Buy) | +85,670 | 85,670 |
Page 8 of 16 · 303 trades